We are live on
!
Find out more
SC
Savant Capital Portfolio holdings
AUM
$20.7B
1-Year Est. Return
19.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.42%
1 Year Est. Return
+19.76%
3 Year Est. Return
+51.75%
5 Year Est. Return
+48.44%
10 Year Est. Return
+194.21%
AUM
$11.8B
AUM Growth
-$912M
(-7.2%)
Cap. Flow
-$902M
Cap. Flow
% of AUM
-7.64%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
1,480
New
58
Increased
229
Reduced
754
Closed
403
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional International High Profitability ETF
DIHP
|
+$143M |
| 2 |
Dimensional US Large Cap Value ETF
DFLV
|
+$77.8M |
| 3 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$64.4M |
| 4 |
JPMorgan US Quality Factor ETF
JQUA
|
+$60.5M |
| 5 |
Avantis International Small Cap Value ETF
AVDV
|
+$53.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$185M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$47M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$46M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$45.4M |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$43.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Financials | 2.23% |
| 3 | Healthcare | 1.72% |
| 4 | Consumer Discretionary | 1.67% |
| 5 | Industrials | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Dr. Reddy's Laboratories
RDY
$9.87B
| $137K | ﹤0.01% |
10,381
-3,569
| -26% | -$49.2K |
|
|
TEF
1027
DELISTED
Telefonica
TEF
| $132K | ﹤0.01% |
28,350
+8,646
| +44% | +$37.1K |
|
1028
GeoPark
GPRK
$633M
| $126K | ﹤0.01% |
15,536
-6,583
| -30% | -$59.1K |
|
1029
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
| $124K | ﹤0.01% |
10,010
-234
| -2% | -$2.93K |
|
1030
Adaptive Biotechnologies
ADPT
$3.59B
| $123K | ﹤0.01% |
16,493
-17,728
| -52% | -$136K |
|
1031
Genworth Financial
GNW
$3.76B
| $113K | ﹤0.01% |
15,917
-1,238
| -7% | -$8.61K |
|
1032
Garrett Motion
GTX
$5.81B
| $109K | ﹤0.01% |
13,018
+2,441
| +23% | +$22.6K |
|
1033
Western Union
WU
$1.98B
| $108K | ﹤0.01% |
10,253
-62,810
| -86% | -$666K |
|
1034
Treace Medical Concepts
TMCI
$280M
| $104K | ﹤0.01% |
+12,394
| New | +$111K |
|
1035
Inter&Co
INTR
$2.47B
| $104K | ﹤0.01% |
18,890
+8,862
| +88% | +$46K |
|
1036
nLIGHT
LASR
$3.88B
| $100K | ﹤0.01% |
+12,914
| New | +$130K |
|
1037
Patterson-UTI
PTEN
$3.98B
| $99.8K | ﹤0.01% |
+12,135
| New | +$102K |
|
1038
Weibo
WB
$2B
| $98.9K | ﹤0.01% |
+10,448
| New | +$106K |
|
1039
ProFrac Holding
ACDC
$731M
| $98.3K | ﹤0.01% |
12,950
-5,996
| -32% | -$46K |
|
1040
Valley National Bancorp
VLY
$7.9B
| $94.4K | ﹤0.01% |
10,614
-36,286
| -77% | -$343K |
|
1041
Turkcell
TKC
$4.68B
| $91.6K | ﹤0.01% |
14,731
-6,131
| -29% | -$43.2K |
|
1042
Sibanye-Stillwater
SBSW
$6.26B
| $90.4K | ﹤0.01% |
+19,734
| New | +$74.8K |
|
1043
Arhaus
ARHS
$1.05B
| $89K | ﹤0.01% |
+10,225
| New | +$109K |
|
1044
Lloyds Banking Group
LYG
$89.5B
| $88K | ﹤0.01% |
23,049
-9,938
| -30% | -$32.9K |
|
|
VNET
1045
VNET Group
VNET
$2.04B
| $84.5K | ﹤0.01% |
+10,305
| New | +$94.5K |
|
1046
Melco Resorts & Entertainment
MLCO
$2.22B
| $84.1K | ﹤0.01% |
+15,961
| New | +$89.9K |
|
|
GRFS
1047
Grifois
GRFS
$5.36B
| $83.2K | ﹤0.01% |
+11,706
| New | +$88.3K |
|
1048
Zegna
ZGN
$3.95B
| $81.4K | ﹤0.01% |
+10,996
| New | +$90.7K |
|
|
EFXT
1049
Enerflex
EFXT
$2.72B
| $79.8K | ﹤0.01% |
+10,329
| New | +$91.3K |
|
1050
Ericsson
ERIC
$32.2B
| $78.1K | ﹤0.01% |
10,061
-7,514
| -43% | -$60.7K |
|
Similar funds
VARA
CB
MIC
GT
EWA
MMH
P
Savant Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Savant Capital held 1,480 positions worth $11.8B, down 7.2% from $12.7B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Savant Capital withdrew a net $902M in Q1 2025, closing 403 positions and reducing 754 holdings. Its most notable exit was DexCom, an estimated $8.58M position sold in full.
By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 5.7% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Savant Capital opened a new position in Leuthold Core ETF worth $12.6M.
- Savant Capital's largest Q1 2025 buy was Leuthold Core ETF: 367,970 shares worth $12.6M.
- Savant Capital added most to Dimensional International High Profitability ETF in Q1 2025, an estimated $143M increase.
- Savant Capital's biggest Q1 2025 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $185M.
- Savant Capital fully exited DexCom in Q1 2025, selling an estimated $8.58M.
- Savant Capital's ten largest holdings make up 44% of its $11.8B portfolio in Q1 2025.
- Savant Capital opened 58 new positions and closed 403 in Q1 2025.
- Savant Capital's portfolio value fell 7.2% quarter-over-quarter to $11.8B.
Based on Savant Capital's 13F filing for Q1 2025, filed 8 May 2025.